HOME >> BIOLOGY >> NEWS
An unlikely new weapon against a deadly bacteria in oysters: A virus

ibrio vulnificus disease reported annually in the United States. Although rare, the disease is severe and often fatal, killing between 50 percent and 75 percent of those who are infected. The bacterium causes flu-like symptoms, followed by high fever, shock and half-dollar sized blood blisters mostly on the patient's legs.

Gulig and Donna Duckworth, a professor of molecular genetics and microbiology and co-author of the article, said because Vibrio resembles the flu or less-harmful diseases, it often remains undiagnosed until its later stages. At that point, the disease does not respond well to antibiotics, whence its high mortality rate, they said. Seeking an alternative to antibiotics, he and Duckworth decided to test the effectiveness of phages in attacking the disease.

The scientists isolated phages that prey naturally on the bacterium from oysters purchased from seafood markets and in mud collected from oyster beds in Florida's coastal waters. They grew the phages in the laboratory, then injected solutions containing concentrated amounts of the virus into the tail veins of mice infected with Vibrio. The result: The researchers found the phages cured the mice even well after they had begun experiencing symptoms of the disease.

"It was very clear that the phage treatment for many of the mice could completely protect them. It could prevent death, and it could essentially clear the mice of bacteria," Gulig said. "We showed that, in typical infections of mice, we get 100 million bacteria per gram of tissue, and in these treated mice we essentially could not detect any bacteria at all."

Gulig said the project didn't compare the phages with similarly timed antibiotic treatments, so the researchers couldn't say which is more effective. But phages have some tantalizing advantages over antibiotics, he said. While antibiotics naturally become diluted and leave the body after a period of time, phages grow and multiply until they have preyed on all t
'"/>

Contact: Paul Gulig
gulig@ufl.edu
352-392-0050
University of Florida
18-Dec-2002


Page: 1 2 3

Related biology news :

1. Goals unlikely to protect Gulf of Mexico shrimp industry
2. First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely
3. Sex selection for social reasons unlikely to skew gender balance in Germany and UK
4. Suppressing entire immune system unlikely to be best way to treat autoimmune diseases, new findings show
5. Depressed heart attack survivors unlikely to change behavior
6. New model of staph drug resistance implicates unlikely protein
7. Novel, even unlikely drugs may curb childhood leukemia
8. One in three physicians unlikely to get routine medical care
9. $18 million bioinformatics center to become weapon against deadly diseases
10. Synthesized molecules studied as weapon to stop cell division in cancer cells
11. Are bacteria turning our own weapons against us?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/23/2019)... ... , ... NanoFUSE is pleased to announce the ... spine and orthopedic use. Bioactive glass is a calcium phosphate coated silica that ... orthopedics for over 30 years and now NanoFUSE Biologics has used advanced research ...
(Date:7/19/2019)... ... July 19, 2019 , ... ... and Crystalline States – Insights from Synchrotron X-ray Pair Distribution (SXPDF) Studies”. The ... with Chris Benmore of Argonne National Laboratory and Gabriel de Araujo of the ...
(Date:7/17/2019)... Pa. (PRWEB) , ... July 15, 2019 , ... ... of computational science expertise exclusively for Life Sciences and Healthcare companies, announces the ... provide critical advisory services and strategic direction to start-up and emerging bio-pharma companies ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... Fla. (PRWEB) , ... June 10, 2019 , ... ... in science and technology in an upcoming episode, scheduled to broadcast 4Q/2019. Check ... the Eppendorf Group) and will educate viewers about how its technology facilitates laboratories ...
(Date:6/11/2019)... POWAY, Calif. (PRWEB) , ... June 11, 2019 ... ... parent company of Personalized Stem Cells Inc. (PSC) , has announced that ... of Public Health, Food and Drug Branch for manufacturing. This is an ...
(Date:5/31/2019)... ... May 29, 2019 , ... For many years, the primary forms of cancer ... breakthrough therapies. Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor ... T cell receptors known as “CARs”. The CAR enables the final product to produce ...
(Date:5/31/2019)... ... May 30, 2019 , ... Object ... announce the strategic acquisition of Metabiologics, Inc., a globally recognized leader in the ... ownership and commercialization rights to a full spectrum of botulinum neurotoxins, as well ...
Breaking Biology Technology:
Cached News: